Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: Clinical and social outcome at two years

British Medical Journal

Volumn 301, Issue 6756, 1990, Pages 837-842

  Jolley, A G ^a   Hirsch, S R ^a   Morrison, E ^a   McRink, A ^a   Wilson, L ^a  

^a Charing Cross   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE DECANOATE; HALOPERIDOL;

ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTRAPYRAMIDAL SYMPTOM; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RELAPSE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0025119859     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.301.6756.837     Document Type: Article

References (18)

1. Van Putten T, Marder SR The dysphoria syndrome and its relation to EPS 1985 595
2. Falloon, I.; Watt, D.C.; Shepherd, M. The social outcome of patients in a trial of long term continuation therapy in schizophrenia: pimozide versus fluphenazine Psvchol Med 1978 10.1017/S0033291700014318 8 265
3. Kane, J.M.; Rifkin, A.; Woerner, M.; Sarantakos, S. Dose response relationships in maintenance drug treatment for schizophrenia Psychopharmacol Bull 1986 6 205
4. Herz, M.I.; Szymanski, H.V.; Simon, J. Intermittent treatment for stable schizophrenic outpatients: an alternative to maintenance medication Am3'Psychiatry 1982 10.1176/ajp.139.7.918 139 918
5. Herz, M.I.; Glazer, W.; Mirza, M.; Mostert, M.; Hafez, H. Treating prodromal episodes to prevent relapse in schizophrenia Br J Psychiatry 1989 155 123 5
6. Carpenter, W.I.; Stephens, W.T.; Rev, A.; Hanlon, T.E.; Heinrichs, D.W. Early intervention versus continuous pharmacotherapy in schizophrenia Psychopharnacol Bull 1982 18 21
7. Pietzcker, A.; Gaebel, W.; Kopcke, M. A German multicentre study of the neuroleptic long term therapy of schizophrenic patients Pharmacopsychiatry 1986 10.1055/s-2007-1017177 19 161
8. Hirsch, SR, Jolley; AG, Manchanda; R, McRink; A. Early intervention medication as an alternative to continuous depot treatment in schizophrenia; preliminary report Psychosocial treatment of schizophrenia 1987
9. Jolley, A.G.; Hirsch, SR, McRink; A, Manchanda; R. Trial of hrief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients; clinical outcome at one year BrMedJ 1989 298 985
10. Carpenter, W.I.; Heinrichs, D.W.; Hanlon, T.E. A comparative trial of pharmacologic strategies in schizophrenia AmJ Psychiatry 1987 10.1176/ajp.144.11.1466 144 1466
11. Davis, J. Comparative doses and costs of antipsychotic medication Arch Gen Psychiatrv 1976 10.1001/archpsyc.1976.01770070088010 33 858
12. Knights, A.; Okasha, M.S.; Salih, M. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in the maintenance of schizophrenic outpatients. Br j Psychiatrv 1979 135 515
13. Guy, W. ECDEU assessment manualJr psychopharmacology 1976
14. Schooler, N.; Hogarty, G.; Mi, Weissman Social adjustment scale II (SAS-II). In: Resource materials for community mental health programme evaluators 1979
15. Glazer, W.M.; Aaronson, H.S.; Prusoff, B.A.; WiBliams, D.H. Assessment of social adjustment in chronic ambulatory schizophrenics J Nem-v Ment Dis 1980 10.1097/00005053-198008000-00008 168 493
16. Kaplan, E.; Meir, P. Nonparametric estimation for incomplete observations Journal ofthe American Statistical Association 1958 53 1 457-8
17. Benedetti, J.; Yuen, K.; Young, L. Life tables and survival function statistical software
18. Wistedt, B.; Jorgensen, A.; Wiles, D. A depot neuroleptic withdrawal study: plasma concentration of fluphenazine and flupenthixol and relapse frequency Psychopharmacol Bull 1982 10.1007/BF00433729 78 301